Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03896243
Recruitment Status : Completed
First Posted : March 29, 2019
Last Update Posted : March 29, 2019
Sponsor:
Information provided by (Responsible Party):
Pınar Yalcin bahat, Kanuni Sultan Suleyman Training and Research Hospital

Brief Summary:
Investigators would like to see the amh values after uterine artery ligation

Condition or disease Intervention/treatment
Uterine Artery Ligation Ovarian Reserve Diagnostic Test: Uterine artery ligation (UAL)

Detailed Description:

Group/cohort:

Uterine artery ligation (UAL) Investigators would like to invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section.

Participants would be evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Control Group:

Investigators would like to invite the patients to the hospital at least 6 months after C-section who delivered baby without any complication.

Participants would be also evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Layout table for study information
Study Type : Observational
Actual Enrollment : 102 participants
Observational Model: Case-Control
Time Perspective: Retrospective
Official Title: Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation
Actual Study Start Date : January 1, 2018
Actual Primary Completion Date : January 1, 2019
Actual Study Completion Date : February 1, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Hormones

Group/Cohort Intervention/treatment
Uterine artery ligation (UAL)

We would like toinvite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section.

They would be evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Diagnostic Test: Uterine artery ligation (UAL)

Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section.

They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC)


Control Group:

We would like to invite the patients to the hospital at least 6 months after C-section who delivered baby without any complication.

They would be also evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Diagnostic Test: Uterine artery ligation (UAL)

Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section.

They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC)





Primary Outcome Measures :
  1. 1.ovarian reserve in patients with uterine artery ligation [ Time Frame: 12 months ]
    calculation of ovarian reserve with amh (ng/ml) after uterine artery ligation due to uterine atony



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   All participants are females undergoing delivery of their baby
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Patients who had uterine artery ligation during C-section. Control group is age-matched postpartum patients.
Criteria

Inclusion Criteria:

  • age 18- 35 years
  • no systemic or endocrine diseases
  • patients who had uterine artery ligation due to atony
  • healthy postpartum patients as controls

Exclusion Criteria:

  • patients with PCOS

    • Pregnancy with IVF or oosit donation
    • Patients with endocrinopathy, diseases which require radiotherapy and chemotherapy etc.
    • Patients with BMI >40

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03896243


Locations
Layout table for location information
Turkey
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey, 34000
Sponsors and Collaborators
Kanuni Sultan Suleyman Training and Research Hospital

Layout table for additonal information
Responsible Party: Pınar Yalcin bahat, Principal Investigator, Kanuni Sultan Suleyman Training and Research Hospital
ClinicalTrials.gov Identifier: NCT03896243    
Other Study ID Numbers: uterinarter
First Posted: March 29, 2019    Key Record Dates
Last Update Posted: March 29, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Supporting Materials: Study Protocol
Statistical Analysis Plan (SAP)
Informed Consent Form (ICF)
Clinical Study Report (CSR)
Analytic Code
Time Frame: 12 months

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Pınar Yalcin bahat, Kanuni Sultan Suleyman Training and Research Hospital:
Uterine atony
amh
Additional relevant MeSH terms:
Layout table for MeSH terms
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs